These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1939760)

  • 1. Blood-brain-barrier disruption in acute Wernicke encephalopathy: MR findings.
    Schroth G; Wichmann W; Valavanis A
    J Comput Assist Tomogr; 1991; 15(6):1059-61. PubMed ID: 1939760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-enhanced MR findings in a pediatric case of Wernicke encephalopathy.
    Harter SB; Nokes SR
    AJNR Am J Neuroradiol; 1995 Apr; 16(4):700-2. PubMed ID: 7611025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Wernicke's encephalopathy associated with hyperemesis gravidarum: magnetic resonance imaging findings.
    Omer SM; al Kawi MZ; al Watban J; Bohlega S; McLean DR; Miller G
    J Neuroimaging; 1995 Oct; 5(4):251-3. PubMed ID: 7579758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mamillary body enhancement on MR as the only sign of acute Wernicke encephalopathy.
    Shogry ME; Curnes JT
    AJNR Am J Neuroradiol; 1994 Jan; 15(1):172-4. PubMed ID: 8141051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR Imaging of nonalcoholic Wernicke encephalopathy: a follow-up study.
    Zhong C; Jin L; Fei G
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2301-5. PubMed ID: 16219836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI demonstration of impairment of the blood-CSF barrier by glucose administration to the thiamin-deficient rat brain.
    Zelaya FO; Rose SE; Nixon PF; Wholohan BT; Bower AJ; Zimitat C; Schoutrop J; Doddrell DM
    Magn Reson Imaging; 1995; 13(4):555-61. PubMed ID: 7674851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of MRI findings in Gayet-Wernicke encephalopathy].
    Lenz V; Vargas MI; Bin JF; Bogorin A; Grebici-Guessoum M; Jacques C; Marin H; Zöllner G; Dietemann JL
    J Neuroradiol; 2002 Sep; 29(3):153-60. PubMed ID: 12447138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion-weighted magnetic resonance imaging findings at early stage of acute Wernicke encephalopathy].
    Hashimoto T; Ueda H; Mitui Y; Kihara M; Takahashi M; Kusunoki S
    Rinsho Shinkeigaku; 2004 Jul; 44(7):422-6. PubMed ID: 15384702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wernicke encephalopathy: MR findings and clinical presentation.
    Weidauer S; Nichtweiss M; Lanfermann H; Zanella FE
    Eur Radiol; 2003 May; 13(5):1001-9. PubMed ID: 12695821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wernicke encephalopathy: MR findings in two patients.
    Opdenakker G; Gelin G; De Surgeloose D; Palmers Y
    Eur Radiol; 1999; 9(8):1620-4. PubMed ID: 10525877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
    Kermode AG; Tofts PS; Thompson AJ; MacManus DG; Rudge P; Kendall BE; Kingsley DP; Moseley IF; du Boulay EP; McDonald WI
    Neurology; 1990 Feb; 40(2):229-35. PubMed ID: 2300240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients.
    Szymanski S; Ashtari M; Zito J; Degreef G; Bogerts B; Lieberman J
    Psychiatry Res; 1991 Nov; 40(3):203-7. PubMed ID: 1780393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity.
    Frank JA; Choyke PL; Girton ME; Austin HA; Sievenpiper C; Inscoe SW; Black JL; Carvlin MJ; Dwyer AJ
    J Comput Assist Tomogr; 1989; 13(3):448-59. PubMed ID: 2723175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wernicke encephalopathy: MR findings in five patients.
    Gallucci M; Bozzao A; Splendiani A; Masciocchi C; Passariello R
    AJR Am J Roentgenol; 1990 Dec; 155(6):1309-14. PubMed ID: 2122685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
    Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
    J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute and chronic cerebral infarctions: SPECT and gadolinium-DTPA enhanced MR imaging.
    Cordes M; Henkes H; Roll D; Eichstädt H; Christe W; Langer M; Felix R
    J Comput Assist Tomogr; 1989; 13(4):567-71. PubMed ID: 2787339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging with diffusion-weighted imaging in acute and chronic Wernicke encephalopathy.
    White ML; Zhang Y; Andrew LG; Hadley WL
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2306-10. PubMed ID: 16219837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wernicke encephalopathy: MR findings in five patients.
    Gallucci M; Bozzao A; Splendiani A; Masciocchi C; Passariello R
    AJNR Am J Neuroradiol; 1990; 11(5):887-92. PubMed ID: 2120991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts.
    Regli L; Regli F; Maeder P; Bogousslavsky J
    Arch Neurol; 1993 Feb; 50(2):175-80. PubMed ID: 8431136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.